Are these 2 top ASX growth shares buys?

City Chic is one of the ASX growth shares with a lot of potential. Is it a buy?

| More on:
Green arrow with green stock prices symbolising a rising share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • This article is about two leading ASX growth shares
  • One is global apparel retailer City Chic which is quickly growing in the US
  • Doctor Care Anywhere is another ASX share which is increasing revenue and profitability

Some of the leading ASX growth shares have seen their share prices dip, or plunge, since the start of the year.

This period of time could be an interesting one for investors looking for opportunities.

A business isn't necessarily a better buy because it has fallen in price. However, for some it certainly can mean it's better value.

With that in mind, here are two top ASX growth shares:

City Chic Collective Ltd (ASX: CCX)

City Chic is one of the world leaders when it comes to retailing plus-size clothing, footwear and accessories for women. It operates a number of brands across different markets including City Chic, Evans and Avenue.

The business continues to see rapid sales growth. In the 26 weeks to 26 December 2021, City Chic's sales revenue rose by 49.8% to $178.3 million. The Americas are particularly driving this strength.

ANZ sales rose 14% to $80.8 million and Americas revenue increased by 62% to $77.2 million. ANZ was hurt by lockdowns, which closed stores. The Americas' growth was attributed to re-engaging the significant Avenue customer base, with Avenue.com trading materially above pre-acquisition levels. The City Chic USA website is also performing strongly.

Global supply chain pressures continue, driven by freight capacity shortages and delivery delays coming out of key areas. But, to combat this, the company invested in additional inventory. This has supported sales.

The business continues to expand organically and with acquisitions. It recently acquired the customer lists, brand and URL of CoEdition – a USA plus-size online marketplace.

Ord Minnett rates it as a buy, with a price target of $6.30. It values the ASX growth share at 28x FY23's estimated earnings.

Doctor Care Anywhere Group PLC (ASX: DOC)

The Doctor Care Anywhere share price has sunk 32% since the start of the 2022 year, despite the ongoing progress that the business is making.

It's a business that enables patients to digitally connect with healthcare professionals.

Doctor Care Anywhere recently released its update for the final quarter of 2021, allowing it to announce some full-year numbers. Group revenue was $46.3 million, representing 115.7% growth year on year.

But it's not just revenue increasing, profitability has gone up too. In the fourth quarter, the gross profit margin increased by 5.4 percentage points to 35.7%.

The growth trajectory continued throughout the fourth quarter of 2021, with revenue and consultations up 35.9% and 22.7% respectively. Approximately 50,500 new patients used the service during the quarter.

A new operating model was announced in December 2021, which is expected to deliver "significant improvements" in both the margin and profitability as it is rolled out during 2022. Patients will now get improved access to the right care, at the right time, for a larger number of people.

Instead of the only option being a 20-minute virtual consultation, patients will also be able to have a 20-minute virtual consultation with an advanced nurse practitioner or a quick consult where a patient completes a questionnaire to be reviewed by a prescribing clinician resulting in written advice or prescription without the need for a real-time video or phone consultation.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Doctor Care Anywhere Group PLC. The Motley Fool Australia has recommended Doctor Care Anywhere Group PLC. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

a business person in a suit and tie directs a pointed finger upwards with a graphic of a rising bar graph and an arrow heading upwards in line with the person's finger.
Growth Shares

These ASX 200 growth shares could be strong buys in March

Goldman Sachs is feeling bullish about these growth stocks.

Read more »

A young man goes over his finances and investment portfolio at home.
Growth Shares

1 ASX growth stock down 30% to buy right now

The market has reacted badly to this ASX 200 company's half-year result. This could be your chance to get in.

Read more »

A man in his 30s with a clipped beard sits at his laptop on a desk with one finger to the side of his face and his chin resting on his thumb as he looks concerned while staring at his computer screen.
Growth Shares

This ASX growth stock is down 25%: Buy, sell, or hold?

Analysts have given their verdict on this beaten down growth share.

Read more »

A woman shows her phone screen and points up.
Growth Shares

2 ASX shares showing 'strong growth' that offer value right now

This pair of quality stocks have upward momentum that can't be denied right now, rising 38% and 15% since the…

Read more »

A young boy sits on his father's shoulders as they flex their muscles at sunrise on a beach
Growth Shares

I'd buy these great ASX growth shares in March

Growth stocks could achieve strong returns.

Read more »

A woman smiles as she sits on the bus using her phone and listening to music through headphones.
Growth Shares

1 ASX stock I think is just as hot as Nvidia (without all the hype)

There is an Australian business going as well as the US chip maker. Check this out.

Read more »

Happy man working on his laptop.
Growth Shares

1 ASX growth stock down 40% to buy right now

Goldman Sachs thinks this beaten down stock could be great value.

Read more »

A woman holds a tape measure against a wall painted with the word BIG, indicating a surge in gowth shares
Growth Shares

Goldman Sachs says these ASX growth shares are destined for big things

There's a reason Goldman has slapped buy ratings on these shares.

Read more »